Ligand Pharmaceuticals LGND Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's accrued interest?
- Ligand Pharmaceuticals (LGND) reported accrued interest of $2.19M in Q1 2026.
- What is the long-term trend for Ligand Pharmaceuticals's accrued interest?
- Over 2 years (2020 to 2025), Ligand Pharmaceuticals's accrued interest has grown at a 67.8% compound annual growth rate (CAGR), from $464K to $1.31M.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.